Literature DB >> 27591499

Malignant Peripheral Nerve Sheath Tumor.

Aaron W James1, Elizabeth Shurell2, Arun Singh3, Sarah M Dry4, Fritz C Eilber5.   

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is the sixth most common type of soft tissue sarcoma. Most MPNSTs arise in association with a peripheral nerve or preexisting neurofibroma. Neurofibromatosis type is the most important risk factor for MPNST. Tumor size and fludeoxyglucose F 18 avidity are among the most helpful parameters to distinguish MPNST from a benign peripheral nerve sheath tumor. The histopathologic diagnosis is predominantly a diagnosis of light microscopy. Immunohistochemical stains are most helpful to distinguish high-grade MPNST from its histologic mimics. Current surgical management of high-grade MPNST is similar to that of other high-grade soft tissue sarcomas.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical neurofibroma; Malignant peripheral nerve sheath tumor; NF1; Neurofibroma; Neurofibromatosis

Mesh:

Substances:

Year:  2016        PMID: 27591499     DOI: 10.1016/j.soc.2016.05.009

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  26 in total

1.  An unusual presentation of intraosseous malignant peripheral nerve sheath tumour of mandible.

Authors:  Sanghoon Lee; Chena Lee; Jin-Kyu Kim; Woong Nam
Journal:  Dentomaxillofac Radiol       Date:  2019-06-13       Impact factor: 2.419

2.  Primary advanced pulmonary synovial sarcoma treated with a multidisciplinary approach.

Authors:  Yosuke Kagawa; Soichi Kitaguchi; Hanae Konishi; Kaori Hashimoto; Osaki Norihito; Tadashi Mizumoto; Ryohei Nishino; Fumihiro Sugahara
Journal:  Int Cancer Conf J       Date:  2020-02-14

3.  Synovial Sarcoma of the Nerve-Clinical and Pathological Features: Case Series and Systematic Review.

Authors:  Stephen Shelby Burks; Ross C Puffer; Iahn Cajigas; David Valdivia; Andrew E Rosenberg; Robert J Spinner; Allan D Levi
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

Review 4.  CT and MRI features of tumors and tumor-like lesions in the abdominal wall.

Authors:  Meng Li; Li Zhang; Xiao-Juan Xu; Zhuo Shi; Xin-Ming Zhao
Journal:  Quant Imaging Med Surg       Date:  2019-11

Review 5.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

6.  A distal ileum malignant peripheral nerve sheath tumor causing intussusception in a patient in China: a case report.

Authors:  Lin-Bo Zhu; Peng-Fei Li; Wei-Hua Xiao; Peng-Bin Zhang; Jun-Qiang Li; Ming-Fei Sun
Journal:  World J Surg Oncol       Date:  2017-01-19       Impact factor: 2.754

7.  Nonoperative Management May Be a Viable Approach to Plexiform Neurofibroma of the Porta Hepatis in Patients with Neurofibromatosis-1.

Authors:  Natesh Yepuri; Rana Naous; Camille Richards; Dilip Kittur; Ajay Jain; Mashaal Dhir
Journal:  HPB Surg       Date:  2018-04-15

8.  BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features.

Authors:  Doron Tolomeo; Antonio Agostini; Gemma Macchia; Alberto L'Abbate; Marco Severgnini; Ingrid Cifola; Maria Antonia Frassanito; Vito Racanelli; Antonio Giovanni Solimando; Felix Haglund; Fredrik Mertens; Clelia Tiziana Storlazzi
Journal:  Hum Cell       Date:  2020-08-27       Impact factor: 4.174

9.  Rare primary malignant peripheral nerve sheath tumor of the left testis: A case report.

Authors:  Dongdong Liu; Yi Mu; Pan Chen; Bangwei Che; Zheming Li; Yili Zhao; Fa Sun; Kaifa Tang
Journal:  Mol Clin Oncol       Date:  2021-05-23

10.  Malignant peripheral nerve sheath tumour of the oesophagus: a case report.

Authors:  Kento Tomizawa; Tatsuya Miyazaki; Arisa Yamaguchi; Ryoya Honda; Marie Hoshino; Mitsuhiro Yanai; Yohei Miyamae; Ryo Kurosaki; Hisashi Shimizu; Kazuhisa Arakawa; Munenori Ide
Journal:  Surg Case Rep       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.